About Us
TWi USA
USA Team
Our Products
For Customers
Authorized Distributors
TWi USA State Licenses
Return Goods Policy
Customer Service Contacts
For Patients
Adverse Event Reporting, Product Complaints & Medical Information(FOr USA Only)
Sorafenib Co-Pay Savings Program
Contact Us
buPROPion Hydrochloride Extended-Release Tablets (XL)
Cyclobenzaprine Hydrochloride Extended-Release Capsules
Diltiazem Hydrochloride Extended-Release Capsules
Dimethyl Fumarate Delayed-Release Capsules
Donepezil tablets
Fenofibric Acid Delayed-Release Capsules
Fluphenazine Hydrochloride Tablets, USP
Guanfacine Hydrochloride Extended-Release Tablets
Hydroquinone Cream
MegestrolAcetate Oral Suspension
Metformin Hydrochloride Extended Release Tablets
Metoprolol Succinate Extended-Release Tablets
Mycophenolic Acid DR Tablets
Nifedipine Extended-Release tablets
Paclitaxel Protein-Bound Particles for Injectable Suspension - (Albumin-Bound)
Propafenone Hydrochloride Extended-Release Capsules, USP
Sevelamer Carbonate Tablets
Sorafenib Tablets, USP
Testosterone Gel, 1.62% CIII
Terbutaline Sulfate tablets
Testosterone Topical Solution CIII, USP
Home > Products > For the United States
Dimethyl Fumarate Delayed-Release Capsules
Route
Oral
Dosage form
Delayed-Release Capsules
Strength
120mg and 240mg
Rx/OTC
Rx
Indication
Indicated for the treatment of relapsing forms of Multiple Sclerosis (MS).
TE Rating
AB
Reference Listed Drug
TECFIDERA TM®
ANDA#
210382
Strength
Form
Product Description
Imprint
Image
How Supplied
NDC Number
HDMA
Sheets
PI
SDS
120mg
Delayed-Release Capsules
Hard gelatin delayed-release capsule. The 120 mg capsules have a green cap and white body, printed with “T127 120 mg” in black ink on the body.
T127 120 mg
14
24979-127-21
240mg
Delayed-Release Capsules
Hard gelatin delayed-release capsule. The 240 mg capsules have a green cap and a green body, printed with “T128 240 mg” in black ink on the body.
T128 240 mg
60
24979-128-04
Back
Top